Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Chinese ethnicity defined as having both parents and 4 grandparents who are Chinese~* Have a normal Body size and weigh at least 50 kg~Exclusion Criteria:~* History of diseases or other condition known to interfere with the absorption, distribution, metabolism or excretion of drugs determined by the investigator~* Current and/or past history of intolerance or hypersensitivity to drugs with a similar chemical structure or mechanism of action to AZD6140 or any ingredient in its formulation~* Symptoms of any clinically significant illness within 2 weeks of screening~* A personal or family history of bleeding diatheses or a reasonable suspicion of vascular abnormalities including aneurysms

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).